Clinical Trial

Impact of Chia Seeds on Human Breast Milk Composition

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The investigators' over-arching hypothesis is that mechanical and compositional properties of chia seeds supplemented during lactation diminish obesity-induced intestinal inflammation and barrier dysfunction. The investigators hypothesize these changes will result in: 1) reduced maternal systemic inflammation (serum CRP and IL-6) and increased gut microbial diversity and richness, 2) reduced HM fat and inflammatory markers, metrics the research team have demonstrated differ in tandem with maternal metabolic health and 3) improved infant growth/body composition. To test these hypotheses, investigators will evaluate chia seed supplementation during lactation in a 6wk multi-site pilot RCT (Aim 1) and through translational studies using human enteroids (Aim 2).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-06; most recent amendment 2026-05-14.
Trial Details
NCT Number NCT07343908
Lead Sponsor University of Oklahoma
Collaborators: Presbyterian Health Foundation, Brigham and Women's Hospital
Conditions Obesity and Overweight, Breastfeeding, Exclusive
Enrollment 80 participants
Start Date 2026-08
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-15